en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


 
3/2014
vol. 52
 
Share:
Share:
more
 
 
abstract:
Editorial

The peculiarities of pathogenesis of NSAID-induced gastrointestinal injuries and current prevention strategies

Anatol Święcicki
,
Antonina Antonienko

Reumatologia 2014; 52, 3: 155–159
Online publish date: 2014/07/31
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely used medications. However, NSAID intake is accompanied by an increased risk of gastroduodenal side effects. These adverse events are largely attributed to the ability of these drugs to suppress prostaglandin synthesis, penetrate the mucosal layer in the acid media of the stomach and damage epithelial cells. However, it is becoming clear that such mediators as prostaglandins, NO and lipoxins can protect the stomach from injury. This injury can largely be prevented through suppression of gastric acid secretion (mainly with proton pump inhibitors). In contrast, the pathogenesis of intestinal injury induced by NSAIDs is less well understood. There is no evidence that suppression of gastric acid secretion will reduce the incidence or severity of NSAID enteropathy. In this review the results of recent studies are described, which will help to clarify some mechanisms of development of NSAID gastropathies and NSAID enteropathies and to improve the treatment of these patients.
keywords:

NSAID gastropathy, cyclooxygenase, lipoxins, prostaglandins, NSAID enteropathy







Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.